Risk factors of recurrent secondary hyperparathyroidism after adequate primary surgical treatment

被引:4
作者
Kuo, Yu-Chi [1 ]
Wang, Shang-Yu [1 ,2 ,3 ]
Hung, Yu-Liang [1 ]
Hsu, Chih-Chieh [1 ]
Kou, Hao-Wei [1 ]
Chen, Ming-Yang [1 ]
Tsai, Chun-Yi [1 ]
Chang, Chih-Hsiang [3 ,4 ]
Wang, Yu-Chao [1 ]
Hsu, Jun-Te [1 ,3 ]
Yeh, Ta-Sen [1 ,3 ]
Lee, Wei-Chen [1 ,3 ]
Yeh, Chun-Nan [1 ,3 ]
机构
[1] Linkou Chang Gung Mem Hosp, Dept Surg, Div Gen Surg, Taoyuan City, Taiwan
[2] Chang Gung Univ, Grad Inst Clin Med Sci, Taoyuan City, Taiwan
[3] Chang Gung Univ, Coll Med, Taoyuan City, Taiwan
[4] Linkou Chang Gung Mem Hosp, Kidney Res Ctr, Dept Nephrol, Taoyuan City, Taiwan
来源
FRONTIERS IN ENDOCRINOLOGY | 2023年 / 14卷
关键词
secondary hyperparathyroidism; parathyroidectomy; end-stage renal disease; recurrence; parathyroid; JAPANESE HEMODIALYSIS-PATIENTS; TOTAL PARATHYROIDECTOMY; RENAL-DISEASE; AUTOTRANSPLANTATION; MANAGEMENT; CINACALCET; PTH;
D O I
10.3389/fendo.2023.1063837
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundSecondary hyperparathyroidism (SHPT) is a common condition in patients with end-stage renal disease (ESRD) who are on dialysis. Parathyroidectomy is a treatment for patients when medical therapy has failed. Recurrence may occur and is indicated for further surgery in the era of improved quality of care for ESRD patients. MethodsWe identified, 1060 patients undergoing parathyroidectomy from January, 2011 to June, 2020. After excluding patients without regular check-up at our institute, primary hyperparathyroidism, or malignancy, 504 patients were enrolled. Sixty-two patients (12.3%, 62/504) were then excluded due to persistent SHPT even after the first parathyroidectomy. We aimed to identify risk factors for recurrent SHPT after the first surgery. ResultsDuring the study period, 20% of patients who underwent parathyroidectomy at our institute (in, 2019) was due to recurrence after a previous parathyroidectomy. There were 442 patients eligible for analysis of recurrence after excluding patients with the persistent disease (n = 62). While 44 patients (9.95%) had recurrence, 398 patients did not. Significant risk factors for recurrent SHPT within 5 years after the first parathyroidectomy, including dialysis start time to first operation time < 3 years (p = 0.046), postoperative PTH >106.5 pg/mL (p < 0.001), and postoperative phosphorus> 5.9 mg/dL (p = 0.016), were identified by multivariate analysis. ConclusionsThe starting time of dialysis to first operation time < 3 years in the patients with dialysis, postoperative PTH> 106.5 pg/mL, and postoperative phosphorus> 5.9 mg/dL tended to have a higher risk for recurrent SHPT within 5 years after primary treatment.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Treatment sf osteopenia secondary to primary hyperparathyroidism
    Yamaguchi, T
    Sugimoto, T
    Chihara, K
    BIOMEDICINE & PHARMACOTHERAPY, 2000, 54 : 104S - 107S
  • [32] REMOTE RESULTS OF SURGICAL TREATMENT OF PRIMARY HYPERPARATHYROIDISM
    Ogorodnikov, A. V.
    Kharnas, S. S.
    Ippolitov, L. I.
    YAKUT MEDICAL JOURNAL, 2019, (04): : 39 - 41
  • [33] Surgical treatment of secondary hyperparathyroidism. A clinical study of 70 patients
    Conzo, Giovanni
    Palazzo, Antonietta
    Della Pietra, Cristina
    Stanzione, Francesco
    Candilio, Giuseppe
    Docimo, Giovanni
    Livrea, Antonio
    ANNALI ITALIANI DI CHIRURGIA, 2010, 81 (06) : 413 - 419
  • [34] Surgical treatment of primary hyperparathyroidism: Our experience
    Casella, Claudio
    Di Fabio, Francesco
    Di Betta, Ernesto
    Nascimbeni, Riccardo
    Salerni, Bruno
    ANNALI ITALIANI DI CHIRURGIA, 2008, 79 (02) : 121 - 127
  • [35] News trends in the surgical treatment of primary hyperparathyroidism
    Chapuis, Y
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2003, 187 (03): : 493 - 502
  • [36] Risk factors for subsequent recurrence after surgical treatment of recurrent pleomorphic adenoma of the parotid gland
    Rooker, Steven A.
    Van Abel, Kathryn M.
    Yin, Linda X.
    Nagelschneider, Alex A.
    Price, Daniel L.
    Olsen, Kerry D.
    Janus, Jeffrey R.
    Kasperbauer, Jan L.
    Moore, Eric J.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2021, 43 (04): : 1088 - 1096
  • [37] Normocalcemia with elevated parathyroid hormone levels after surgical treatment of primary hyperparathyroidism
    Denizot, A
    Pucini, M
    Chagnaud, C
    Botti, G
    Henry, JF
    AMERICAN JOURNAL OF SURGERY, 2001, 182 (01) : 15 - 19
  • [38] FACTORS RELATED TO THE RECURRENT HYPERFUNCTION OF AUTOGRAFTS AFTER TOTAL PARATHYROIDECTOMY IN PATIENTS WITH SEVERE SECONDARY HYPERPARATHYROIDISM
    TANAKA, Y
    SEO, H
    TOMINAGA, Y
    FUNAHASHI, H
    MATSUI, N
    TAKAGI, H
    SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 1993, 23 (03): : 220 - 227
  • [39] Safety and efficiency of microwave ablation for recurrent and persistent secondary hyperparathyroidism after parathyroidectomy: A retrospective pilot study
    Yu, Ming-An
    Yao, Li
    Zhang, Ling
    Peng, Lili
    Zhuo, Li
    Zhang, Yumei
    Li, Wenge
    Lv, Ming-De
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2016, 32 (02) : 180 - 186
  • [40] The Importance of Cryopreserved Parathyroid Tissue Autotransplantation in the Hypoparathyroidism Treatment after Secondary Hyperparathyroidism Surgery
    Idiz, Ufuk Oguz
    Yucesan, Emrah
    Goncu, Beyza
    Ozdemir, Burcu
    Aysan, Erhan
    Gurol, Ali Osman
    ISTANBUL MEDICAL JOURNAL, 2021, 22 (04): : 275 - 279